Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2020-10-13 Purchase | 2020-10-15 7:18 pm | Aimmune Therapeutics Inc. | AIMT | Societe des Produits Nestle S.A. 10% Owner | 54,117,287 | $34.5 | $1,867,046,402 | 36,661,564 (Indirect Direct) | View |
2020-10-13 Sale | 2020-10-14 4:15 pm | Aimmune Therapeutics Inc. | AIMT | Oxtoby Andrew Chief Commercial Officer | 20,250 | $34.5 | $698,625 | 0 (Direct) | View |
2020-10-13 Sale | 2020-10-14 4:15 pm | Aimmune Therapeutics Inc. | AIMT | Sheehy Douglas T. See Remarks | 36,875 | $34.5 | $1,272,188 | 0 (Direct) | View |
2020-10-13 Sale | 2020-10-14 4:15 pm | Aimmune Therapeutics Inc. | AIMT | Dallas Jayson Donald Alexander President and CEO | 89,250 | $34.5 | $3,079,125 | 0 (Direct) | View |
2020-10-13 Sale | 2020-10-14 4:15 pm | Aimmune Therapeutics Inc. | AIMT | MCDADE MARK Director | 7,840 | $34.5 | $270,480 | 0 (Direct) | View |
2020-10-13 Sale | 2020-10-14 4:15 pm | Aimmune Therapeutics Inc. | AIMT | Behar Gregory Director | 7,840 | $34.5 | $270,480 | 10,192 (Direct) | View |
2020-10-13 Sale | 2020-10-14 4:15 pm | Aimmune Therapeutics Inc. | AIMT | HAUMANN BRETT K Director | 13,313 | $34.5 | $459,299 | 0 (Direct) | View |
2020-10-13 Sale | 2020-10-14 4:15 pm | Aimmune Therapeutics Inc. | AIMT | Seltzer Stacey Denenberg Director | 7,840 | $34.5 | $270,480 | 0 (Direct) | View |
2020-10-13 Sale | 2020-10-14 4:15 pm | Aimmune Therapeutics Inc. | AIMT | BJERKHOLT ERIC Chief Financial Officer | 23,905 | $34.5 | $824,723 | 0 (Direct) | View |
2020-10-13 Sale | 2020-10-14 4:15 pm | Aimmune Therapeutics Inc. | AIMT | Iwicki Mark T Director | 7,840 | $34.5 | $270,480 | 0 (Direct) | View |
2020-10-13 Sale | 2020-10-14 4:15 pm | Aimmune Therapeutics Inc. | AIMT | ENRIGHT PATRICK G Director | 7,840 | $34.5 | $270,480 | 0 (Indirect Direct) | View |
2020-10-13 Sale | 2020-10-14 4:15 pm | Aimmune Therapeutics Inc. | AIMT | ADELMAN DANIEL C MD Chief Medical Officer | 22,343 | $34.5 | $770,834 | 0 (Direct) | View |
2020-10-13 Sale | 2020-10-14 4:15 pm | Aimmune Therapeutics Inc. | AIMT | FALBERG KATHRYN E Director | 7,840 | $34.5 | $270,480 | 0 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2020-10-10 Equity Swap | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | Oxtoby Andrew Chief Commercial Officer | 6,345 | $34.5 | 0 (Direct) | View |
2020-10-10 Equity Swap | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | Sheehy Douglas T. See Remarks | 47,450 | $34.5 | 0 (Direct) | View |
2020-10-10 Equity Swap | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | Dallas Jayson Donald Alexander President and CEO | 30,422 | $34.5 | 0 (Direct) | View |
2020-10-10 Equity Swap | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | MCDADE MARK Director | 26,852 | $34.5 | 0 (Direct) | View |
2020-10-13 Other | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | Behar Gregory Director | 10,192 | $0 | 10,192 (Direct) | View |
2020-10-10 Equity Swap | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | HAUMANN BRETT K Director | 6,250 | $34.5 | 0 (Direct) | View |
2020-10-10 Equity Swap | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | Seltzer Stacey Denenberg Director | 10,221 | $34.5 | 0 (Direct) | View |
2020-10-10 Equity Swap | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | BJERKHOLT ERIC Chief Financial Officer | 27,805 | $34.5 | 0 (Direct) | View |
2020-10-10 Equity Swap | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | Iwicki Mark T Director | 39,567 | $34.5 | 0 (Direct) | View |
2020-10-10 Equity Swap | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | ENRIGHT PATRICK G Director | 162,258 | $34.5 | 0 (Direct) | View |
2020-10-10 Equity Swap | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | ADELMAN DANIEL C MD Chief Medical Officer | 41,464 | $34.5 | 0 (Direct) | View |
2020-10-10 Equity Swap | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | FALBERG KATHRYN E Director | 135,086 | $34.5 | 0 (Direct) | View |
2020-10-02 Exercise | 2020-10-05 9:20 pm | N/A 2026-06-24 | Aimmune Therapeutics Inc. | AIMT | ADELMAN DANIEL C MD Chief Medical Officer | 34,932 | $0 | 198,875 (Direct) | View |
2020-10-02 Exercise | 2020-10-05 9:20 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | ADELMAN DANIEL C MD Chief Medical Officer | 34,932 | $11.45 | 198,875 (Direct) | View |
2020-10-05 Exercise | 2020-10-05 9:14 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | Sheehy Douglas T. See Remarks | 30,888 | $12.95 | 107,787 (Direct) | View |
2020-10-05 Exercise | 2020-10-05 9:14 pm | N/A 2026-04-29 | Aimmune Therapeutics Inc. | AIMT | Sheehy Douglas T. See Remarks | 30,888 | $0 | 107,787 (Direct) | View |
2020-10-05 Exercise | 2020-10-05 9:13 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | BJERKHOLT ERIC Chief Financial Officer | 5,200 | $19.44 | 314,641 (Direct) | View |
2020-10-05 Exercise | 2020-10-05 9:13 pm | N/A 2027-04-28 | Aimmune Therapeutics Inc. | AIMT | BJERKHOLT ERIC Chief Financial Officer | 5,200 | $0 | 314,641 (Direct) | View |
2020-09-21 Other | 2020-09-23 9:35 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | ENRIGHT PATRICK G Director | 6,204,831 | $0 | 6,374,929 (Indirect) | View |
2020-09-15 Tax Withholding | 2020-09-16 5:20 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | Sheehy Douglas T. See Remarks | 840 | $34.25 | 54,538 (Direct) | View |
2020-09-15 Tax Withholding | 2020-09-16 5:19 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | Oxtoby Andrew Chief Commercial Officer | 840 | $34.25 | 26,595 (Direct) | View |
2020-09-15 Tax Withholding | 2020-09-16 5:18 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | BJERKHOLT ERIC Chief Financial Officer | 840 | $34.25 | 44,547 (Direct) | View |
2020-09-15 Tax Withholding | 2020-09-16 5:17 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | Dallas Jayson Donald Alexander President and CEO | 1,642 | $34.25 | 117,034 (Direct) | View |
2020-09-15 Tax Withholding | 2020-09-16 5:17 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | ADELMAN DANIEL C MD Chief Medical Officer | 840 | $34.25 | 28,875 (Direct) | View |
2020-06-22 Tax Withholding | 2020-06-26 5:06 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | Dallas Jayson Donald Alexander President and CEO | 7,907 | $18.02 | 118,676 (Direct) | View |